Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug;80(6):570-587.
doi: 10.1007/s00393-021-01056-6.

[Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination]

[Article in German]
Christof Specker  1   2 , Peer Aries  3   4 , Jürgen Braun  3   5 , Gerd Burmester  3   6 , Rebecca Fischer-Betz  3   7 , Rebecca Hasseli  3   8 , Julia Holle  3   9 , Bimba Franziska Hoyer  3   10 , Christof Iking-Konert  3   11 , Andreas Krause  3   12 , Klaus Krüger  3   13 , Martin Krusche  3   6 , Jan Leipe  3   14 , Hanns-Martin Lorenz  3   15 , Frank Moosig  3   9 , Rotraud Schmale-Grede  16 , Matthias Schneider  3   7 , Anja Strangfeld  3   17 , Reinhard Voll  3   18 , Anna Voormann  3 , Ulf Wagner  3   19 , Hendrik Schulze-Koops  20   21
Affiliations
Review

[Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination]

[Article in German]
Christof Specker et al. Z Rheumatol. 2021 Aug.
No abstract available

PubMed Disclaimer

References

    1. Schulze-Koops H, Holle J, Moosig F, et al. Aktuelle Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie für die Betreuung von Patienten mit rheumatischen Erkrankungen während der SARS-CoV-2/Covid 19-Pandemie. Z Rheumatol. 2020;79(4):385–388. doi: 10.1007/s00393-020-00799-y. - DOI - PMC - PubMed
    1. Schulze-Koops H, Specker C, Iking-Konert C, Holle J, Moosig F, Krueger K. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic. Ann Rheum Dis. 2020;79(6):840–842. doi: 10.1136/annrheumdis-2020-217628. - DOI - PubMed
    1. Schulze-Koops H, Krueger K, Specker C. No advice to discontinue antirheumatic therapy for non-medical reasons in light of SARS-CoV-2. Response to: “Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic” by Fragoulis et al. Ann Rheum Dis. 2020 doi: 10.1136/annrheumdis-2020-217987. - DOI - PubMed
    1. Schulze-Koops H, Iking-Konert C, Leipe J, Hoyer BF, Holle J, Moosig F, Aries P, Burmester G, Fiehn C, Krause A, Lorenz HM, Schneider M, Sewerin P, Voormann A, Wagner U, Krüger K, Specker C, Kommission Pharmakotherapie. Vorstand der Deutschen Gesellschaft für Rheumatologie Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie e. V. für die Betreuung von Patienten mit entzündlich rheumatischen Erkrankungen im Rahmen der SARS-CoV-2/COVID-19-Pandemie – Update Juli 2020. Z Rheumatol. 2020;79(7):679–685. doi: 10.1007/s00393-020-00851-x.PMID:. - DOI - PMC - PubMed
    1. Schulze-Koops H, Krüger K, Hoyer BF, Leipe J, Iking-Konert C, Specker C, Commission for Pharmacotherapy and the Board of Directors of the German Society for Rheumatology Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2—methodology, key messages and justifying information. Baillieres Clin Rheumatol. 2021 doi: 10.1093/rheumatology/keab072. - DOI - PMC - PubMed

Substances